Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
2003 1
2004 3
2005 1
2006 5
2007 1
2008 1
2009 4
2010 5
2011 2
2016 1
2019 1
2020 6
2021 1
2022 1
2023 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
Genetic trajectory and immune microenvironment of lung-specific oligometastatic colorectal cancer.
Ottaiano A, Circelli L, Lombardi A, Scala S, Martucci N, Galon J, Buonanno M, Scognamiglio G, Botti G, Hermitte F, Savarese G, D'Amore L, Tatangelo F, Di Mauro A, Liguori G, Trotta AM, Napolitano M, Capozzi M, Tafuto S, Perri F, La Rocca A, Caraglia M, Nasti G. Ottaiano A, et al. Among authors: hermitte f. Cell Death Dis. 2020 Apr 24;11(4):275. doi: 10.1038/s41419-020-2480-6. Cell Death Dis. 2020. PMID: 32332709 Free PMC article.
Evolution of Mutational Landscape and Tumor Immune-Microenvironment in Liver Oligo-Metastatic Colorectal Cancer.
Ottaiano A, Caraglia M, Di Mauro A, Botti G, Lombardi A, Galon J, Luce A, D'Amore L, Perri F, Santorsola M, Hermitte F, Savarese G, Tatangelo F, Granata V, Izzo F, Belli A, Scala S, Delrio P, Circelli L, Nasti G. Ottaiano A, et al. Among authors: hermitte f. Cancers (Basel). 2020 Oct 21;12(10):3073. doi: 10.3390/cancers12103073. Cancers (Basel). 2020. PMID: 33096795 Free PMC article.
How basal are triple-negative breast cancers?
Bertucci F, Finetti P, Cervera N, Esterni B, Hermitte F, Viens P, Birnbaum D. Bertucci F, et al. Among authors: hermitte f. Int J Cancer. 2008 Jul 1;123(1):236-40. doi: 10.1002/ijc.23518. Int J Cancer. 2008. PMID: 18398844 Free article.
Analytical validation of the Immunoscore and its associated prognostic value in patients with colon cancer.
Marliot F, Chen X, Kirilovsky A, Sbarrato T, El Sissy C, Batista L, Van den Eynde M, Haicheur-Adjouri N, Anitei MG, Musina AM, Scripcariu V, Lagorce-Pagès C, Hermitte F, Galon J, Fieschi J, Pagès F. Marliot F, et al. Among authors: hermitte f. J Immunother Cancer. 2020 May;8(1):e000272. doi: 10.1136/jitc-2019-000272. J Immunother Cancer. 2020. PMID: 32448799 Free PMC article.
Safety, Antitumor Activity, and T-cell Responses in a Dose-Ranging Phase I Trial of the Oncolytic Peptide LTX-315 in Patients with Solid Tumors.
Spicer J, Marabelle A, Baurain JF, Jebsen NL, Jøssang DE, Awada A, Kristeleit R, Loirat D, Lazaridis G, Jungels C, Brunsvig P, Nicolaisen B, Saunders A, Patel H, Galon J, Hermitte F, Camilio KA, Mauseth B, Sundvold V, Sveinbjørnsson B, Rekdal Ø. Spicer J, et al. Among authors: hermitte f. Clin Cancer Res. 2021 May 15;27(10):2755-2763. doi: 10.1158/1078-0432.CCR-20-3435. Epub 2021 Feb 4. Clin Cancer Res. 2021. PMID: 33542073 Clinical Trial.
30 results